Evaxion Biotech has announced that Dr. Lars Staal Wegner is resigning as CEO and will be replaced by Dr. Per Norlén. Wegner will remain with the company in an advisory role.

Norlén is a physician and board-certified specialist in clinical pharmacology. He has over 20 years of working in clinical drug development and management at biopharma organizations. 

“After ten great years at Evaxion, I am happy to leave the seat to Per, and I am proud of what we as a company have accomplished in that time,” Dr. Wegner said in a statement.